Wall Street Analysts Think EyePoint Pharmaceuticals (EYPT) Could Surge 31.27%: Read This Before Placing a Bet

EyePoint Pharmaceuticals (EYPT) closed the last trading session at $29.71, gaining 30.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 39 indicates a 31.3% upside potential.The average comprises eight short-term price targets ranging from a low of $30 to a high of$ 55, with a standard deviation of $8.82. While the lowest estimate indicates an increase of 1% from the current pric ...